Σεπ222025ΝέαFeaturedΑνακοινώσεις Δείτε ΕΔΩ το σχετικό ΦΕΚ Κατηγορίες Νέα, , Featured, Ανακοινώσεις22 Σεπτεμβρίου 2025 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real- World Analysis of the IMMUreal CohortΕπόμενοNext post:Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind, placebo-controlled, multicenter phase II studyΣχετικά ΆρθραΔελτίο Τύπου για τη Διεθνή Ημέρα Προϊούσας Οικογενούς Ενδοηπατικής Χολόστασης 2025 Progressive Familial Intrahepatic Cholestasis (PFIC) Awareness Day2 Οκτωβρίου 2025Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis29 Σεπτεμβρίου 2025Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study29 Σεπτεμβρίου 2025Healthy eating and physical activity significantly lower sex-specific alcohol-attributable liver mortality in the United States29 Σεπτεμβρίου 2025Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind, placebo-controlled, multicenter phase II study25 Σεπτεμβρίου 2025Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real- World Analysis of the IMMUreal Cohort22 Σεπτεμβρίου 2025
Δελτίο Τύπου για τη Διεθνή Ημέρα Προϊούσας Οικογενούς Ενδοηπατικής Χολόστασης 2025 Progressive Familial Intrahepatic Cholestasis (PFIC) Awareness Day2 Οκτωβρίου 2025
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis29 Σεπτεμβρίου 2025
Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study29 Σεπτεμβρίου 2025
Healthy eating and physical activity significantly lower sex-specific alcohol-attributable liver mortality in the United States29 Σεπτεμβρίου 2025
Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind, placebo-controlled, multicenter phase II study25 Σεπτεμβρίου 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real- World Analysis of the IMMUreal Cohort22 Σεπτεμβρίου 2025